Senseonics Holdings, Inc. reported $49M of revenue over the trailing twelve months, +91% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $49M (to Q2 2026). Net income: −$109M, trailing twelve months to Q2 2026. Free cash flow: −$97M, trailing twelve months to Q2 2026. Operating margin: −227%, trailing twelve months to Q2 2026.

SENSSenseonics Holdings, Inc.

Healthcare

$5.39-46% 1Y

$5.39

$4.8652 weeks$10.33

SENS as reported

Senseonics Holdings, Inc. reported $49M of revenue over the trailing twelve months, +91% on the year before. 10 reported series are charted on this page, each one as filed.

$49M

Revenue, trailing twelve months · to Q2 2026 · +91% against the twelve months before

Net income: −$109M
Net income · +60% year on year · trailing twelve months to Q2 2026
Free cash flow: −$97M
Free cash flow · +75% year on year · trailing twelve months to Q2 2026
Operating margin: −227%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for SENS, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$49M	+91%	Q2 2026
Net income	−$109M	+60%	Q2 2026
EPS	−$2.24	+13%	Q2 2026
Gross margin	54%	n/a	Q2 2026
Operating margin	−227%	n/a	Q2 2026
Net margin	−229%	n/a	Q2 2026
ROE	−142%	n/a	Q2 2026
ROA	−62%	n/a	Q2 2026
ROIC	−1917%	n/a	Q2 2026
Free cash flow	−$97M	+75%	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.